However, it should be noted that this sexual dimorphism also exists for the genitourinary side effects of SGLT2 inhibitors [41], which represent potential precipitating factors for DKA, along with respiratory and gastrointestinal infections such as COVID-19 [47]. This evidence concerns the gene SLC5A2 and COVID-19.